CM Hospitalar S/A (BVMF:VVEO3)
Brazil
· Delayed Price · Currency is BRL 1.200
-0.040 (-3.23%)
At close: Apr 23, 2025, 4:55 PM GMT-3
CM Hospitalar S/A Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 11,583 | 11,084 | 8,747 | 6,219 | 4,413 | Upgrade
|
| Revenue Growth (YoY) | 4.51% | 26.72% | 40.65% | 40.91% | 46.96% | Upgrade
|
| Cost of Revenue | 10,277 | 9,349 | 7,350 | 5,121 | 3,775 | Upgrade
|
| Gross Profit | 1,306 | 1,735 | 1,397 | 1,097 | 638.47 | Upgrade
|
| Selling, General & Admin | 1,473 | 1,146 | 863.53 | 671.86 | 420.34 | Upgrade
|
| Other Operating Expenses | 537.62 | -24.34 | 10.28 | -71.19 | 18.64 | Upgrade
|
| Operating Expenses | 2,121 | 1,113 | 879.77 | 602.01 | 441.2 | Upgrade
|
| Operating Income | -814.99 | 621.46 | 516.89 | 495.3 | 197.27 | Upgrade
|
| Interest Expense | -489.45 | -469.03 | - | -386.75 | -351.45 | Upgrade
|
| Interest & Investment Income | 91.12 | 103.08 | - | 303.31 | 344.01 | Upgrade
|
| Earnings From Equity Investments | -11.86 | -1.68 | -3.53 | -3 | -0.25 | Upgrade
|
| Currency Exchange Gain (Loss) | -54.93 | 17.39 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -275.31 | -149.39 | -305.28 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -1,555 | 121.83 | 208.08 | 408.85 | 189.59 | Upgrade
|
| Asset Writedown | -45.58 | - | - | - | - | Upgrade
|
| Legal Settlements | 9.44 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | 16.67 | - | - | - | Upgrade
|
| Pretax Income | -1,592 | 138.5 | 208.08 | 408.85 | 189.59 | Upgrade
|
| Income Tax Expense | -176.06 | -221.42 | -51.65 | 13.7 | 67.82 | Upgrade
|
| Earnings From Continuing Operations | -1,415 | 359.92 | 259.73 | 395.16 | 121.77 | Upgrade
|
| Net Income | -1,415 | 359.92 | 259.73 | 395.16 | 121.77 | Upgrade
|
| Net Income to Common | -1,415 | 359.92 | 259.73 | 395.16 | 121.77 | Upgrade
|
| Net Income Growth | - | 38.57% | -34.27% | 224.52% | 240.63% | Upgrade
|
| Shares Outstanding (Basic) | 318 | 300 | 284 | 262 | 225 | Upgrade
|
| Shares Outstanding (Diluted) | 318 | 300 | 284 | 262 | 225 | Upgrade
|
| Shares Change (YoY) | 5.88% | 5.74% | 8.48% | 16.35% | 44.65% | Upgrade
|
| EPS (Basic) | -4.46 | 1.20 | 0.92 | 1.51 | 0.54 | Upgrade
|
| EPS (Diluted) | -4.46 | 1.20 | 0.92 | 1.51 | 0.54 | Upgrade
|
| EPS Growth | - | 31.05% | -39.41% | 178.91% | 135.49% | Upgrade
|
| Free Cash Flow | -47.47 | -1,064 | 380.51 | 242.16 | 136.25 | Upgrade
|
| Free Cash Flow Per Share | -0.15 | -3.54 | 1.34 | 0.93 | 0.61 | Upgrade
|
| Dividend Per Share | - | - | 0.277 | 0.405 | - | Upgrade
|
| Dividend Growth | - | - | -31.57% | - | - | Upgrade
|
| Gross Margin | 11.27% | 15.65% | 15.97% | 17.64% | 14.47% | Upgrade
|
| Operating Margin | -7.04% | 5.61% | 5.91% | 7.96% | 4.47% | Upgrade
|
| Profit Margin | -12.22% | 3.25% | 2.97% | 6.35% | 2.76% | Upgrade
|
| Free Cash Flow Margin | -0.41% | -9.60% | 4.35% | 3.89% | 3.09% | Upgrade
|
| EBITDA | -621.21 | 798.21 | 693.25 | 593.49 | 279.54 | Upgrade
|
| EBITDA Margin | -5.36% | 7.20% | 7.93% | 9.54% | 6.33% | Upgrade
|
| D&A For EBITDA | 193.77 | 176.75 | 176.36 | 98.19 | 82.27 | Upgrade
|
| EBIT | -814.99 | 621.46 | 516.89 | 495.3 | 197.27 | Upgrade
|
| EBIT Margin | -7.04% | 5.61% | 5.91% | 7.96% | 4.47% | Upgrade
|
| Effective Tax Rate | - | - | - | 3.35% | 35.77% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.